Abbott Reports Second-Quarter 2023 Results; Increases Outloo

/PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2023....

Related Keywords

China , France , Robertb Ford , , Linkedin , Drug Administration , Abbott Laboratories , Core Laboratory , Acelis Connected Health , Cardiovascular Systems Inc , Facebook , European Union Medical Device Regulations , Systems Inc , Medical Devices , Established Pharmaceuticals , Ablation Catheter , Sensor Enabled , Cardiovascular Systems , Consolidated Statement , Pediatric Nutrition , Adult Nutrition , Rapid Diagnostics , Heart Failure , Emerging Markets , Diabetes Care , Structural Heart , Aristocrats Index , Investor Relations , Private Securities Litigation Reform Act , Caution Concerning Forward Looking , Annual Report , Quarter Ended June , Operating Cost , Specified Items , Common Share , Common Shares , Diluted Earnings , Half Ended June , First Half Ended June , Financial Information , European Union , Medical Device Regulations , Vitro Diagnostics Medical Device Regulations , Gross Margin , Abbott ,